FDA 483 - Changzhou Pharmaceutical Factory - January 12, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Changzhou Pharmaceutical Factory Company Ltd. was inspected and cited for multiple significant deficiencies in its drug and API manufacturing operations. Observations included inadequate equipment cleaning and maintenance procedures, failure to thoroughly investigate discrepancies and report critical deviations, and insufficient visual examination of reserve samples for seal integrity. These issues indicate a lack of robust quality control and adherence to established procedures, potentially impacting product quality and safety.
ID · cd894f30-d17f-4d2d-b9f2-85a72e934cea